Production Equipment Technician
About the job
- An associate degree in Mechanical or Electromechanical technology is required.
- A minimum of 10 years of experience in a similar role in the pharmaceutical manufacturing and packaging industry is specified as preferable.
- Competency in mechanical, pneumatic, and hydraulic devices, and basic electrical systems, including gears, gearboxes, bearings, belts and conveyors, cutters, and valves used in pharmaceutical or food manufacturing and packaging equipment.
- Competency in mechanical fabrication using lathe machines, grinders, polishers, and tools.
- Ability to communicate and collaborate in Arabic and English.
- Ability to work shifts.
- Ability to use an enterprise resource planning system for maintenance reporting and purchasing requisitions in English.
- Knowledge of good manufacturing practices and environmental, health, and safety practices.
- Install, troubleshoot, maintain, and overhaul production-area equipment and its mechanical, electrical, electromechanical, pneumatic, and hydraulic devices to support smooth operation across shifts and address breakdowns.
- Execute routine and non-routine maintenance activities, document observations, work progress, abnormalities, and spare-parts usage in enterprise resource planning work-order documents and maintenance work instructions, and escalate issues to supervisors or managers.
- Execute planned maintenance activities and document them according to standard operating procedures and other implemented documentation.
- Communicate regularly about spare-parts needs and additional work, and communicate with other departments in English and Arabic.
- Fabricate parts and components in-house using machinery available at the site.
- Follow standard operating procedures, work orders, and standard work instructions while complying with safety and quality requirements.
- Report floor abnormalities, particularly those involving production equipment, to direct supervisors and managers; report near misses and quality or environmental, health, and safety incidents through the site system.
- Maintain engineering tools in clean, serviceable condition for use in a good manufacturing practice environment, observing contamination and cross-contamination risks and precautions.
- Generate ideas for improving machine performance and provide feedback to the supervisor.
- Participate in assigned machine modification and upgrade tasks.
- Provide the technical supervisor with feedback about required spare parts for production equipment.
About the company
EVA Pharma develops and manufactures affordable medicines for global markets, focusing on 12 therapeutic areas such as anti-infectives, metabolic health, oncology, and pediatrics. It operates four manufacturing facilities with a 5,000-strong team and produces over one million healthcare products daily. The company runs two regional research centers that use AI-driven prediction and mRNA R&D to develop biological products and first-of-its-kind capabilities in the Middle East and Africa. EVA Pharma distributes its products to more than 60 countries and seeks to expand access to high-quality medicines worldwide. Its differentiation comes from its scale, regional R&D capabilities, and commitment to sustainable access, aiming to meet pressing, unmet disease needs with reliable supply.
Company Size
1,001-5,000
Company Stage
N/A
Total Funding
N/A
Headquarters
Al Sharikat, Egypt
Founded
1997
Get referred to Eva Pharma
See people who can refer or advise you
Simplify's Take
What believers are saying
- Egypt’s December 2024 insulin approval opens exportable manufacturing revenues and credibility with regulators.
- November 2025 EVA Pharma Oncology targets 22 million packs annually, with 11 more treatments planned.
- Access-heavy partnerships with Gilead, BeiGene, and Porton create multiple near-term revenue streams.
What critics are saying
- Gilead’s generic lenacapavir supply starts 2027, so execution delays destroy EVA Pharma’s moat.
- Oncology launches need Egypt market uptake; BRUKINSA, TEVIMBRA, and seven in-house products face entrenched competitors.
- Any FDA, EDA, or Gilead tech-transfer setback blocks EVA Pharma’s pivot into high-value biologics.
What makes Eva Pharma unique
- Egypt’s 2024 Lilly insulin approval proves EVA Pharma can localize complex biologics manufacturing.
- The 2024 Gilead lenacapavir license makes EVA Pharma Africa’s sole local generic producer.
- The 2025 BeiGene deal and 2025 Porton MOU extend EVA Pharma beyond generics into oncology and CAR-T.
Help us improve and share your feedback! Did you find this helpful?